Healthpeak Properties (NYSE:DOC) Cut to “Sell” at Wall Street Zen

Wall Street Zen cut shares of Healthpeak Properties (NYSE:DOC) from a hold rating to a sell rating in a report published on Saturday morning,Wall Street Zen reports.

Other research analysts have also issued reports about the stock. Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Cantor Fitzgerald cut their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Wednesday, November 4th. UBS Group reduced their price target on Healthpeak Properties from $21.50 to $20.00 and set a “neutral” rating for the company in a report on Tuesday, October 13th. Jefferies Financial Group assumed coverage on Healthpeak Properties in a report on Tuesday, September 15th. They set a “hold” rating and a $21.00 price target for the company. Finally, Robert W. Baird boosted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research report on Thursday, August 13th. Four analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $21.47.

Healthpeak Properties Trading Up 2.0%

NYSE DOC opened at $20.67 on Friday. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $22.95. The company has a current ratio of 1.29, a quick ratio of 3.02 and a debt-to-equity ratio of 0.87. The stock has a 50 day moving average of $19.74 and a 200-day moving average of $19.21. The company has a market cap of $14.25 billion, a PE ratio of 11.08, a PEG ratio of 2.49 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.41). Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. The firm had revenue of $820.89 million for the quarter, compared to analyst estimates of $739.18 million. During the same quarter in the previous year, the firm posted $0.46 earnings per share. Healthpeak Properties’s quarterly revenue was up 16.3% on a year-over-year basis. On average, equities research analysts anticipate that Healthpeak Properties will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be issued a dividend of $0.1017 per share. This represents a $1.22 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, December 18th. Healthpeak Properties’s dividend payout ratio is 225.93%.

Insider Activity

In related news, EVP Ankit B. Patadia sold 6,115 shares of the firm’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $20.78, for a total value of $127,069.70. Following the transaction, the executive vice president owned 2,838 shares in the company, valued at approximately $58,973.64. This trade represents a 68.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.23% of the company’s stock.

Institutional Trading of Healthpeak Properties

A number of institutional investors and hedge funds have recently made changes to their positions in DOC. State Street Corp increased its stake in shares of Healthpeak Properties by 92.3% in the 2nd quarter. State Street Corp now owns 93,267,685 shares of the real estate investment trust’s stock valued at $1,995,928,000 after purchasing an additional 44,767,085 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Healthpeak Properties by 60.3% in the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after buying an additional 5,815,189 shares in the last quarter. Bank of America Corp DE boosted its stake in Healthpeak Properties by 27.5% in the first quarter. Bank of America Corp DE now owns 11,887,795 shares of the real estate investment trust’s stock valued at $195,316,000 after buying an additional 2,563,407 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Healthpeak Properties by 2.8% in the first quarter. Dimensional Fund Advisors LP now owns 10,583,736 shares of the real estate investment trust’s stock valued at $173,896,000 after acquiring an additional 290,589 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in Healthpeak Properties by 83.4% in the second quarter. Envestnet Asset Management Inc. now owns 7,761,469 shares of the real estate investment trust’s stock valued at $166,095,000 after acquiring an additional 3,530,429 shares during the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities.

The company’s properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.

Based in Denver, Colorado, Healthpeak traces its history to a healthcare property company founded in 1985.